Our Company

We believe proton therapy should be accessible to every patient needing treatment. We also understand this belief is only achievable if proton therapy is a viable solution in the broad healthcare market. We started Allied Health Management knowing proton therapy is a difficult service to plan, build and manage, so we combined the expertise of multiple industry leaders to create a team that can tackle any challenge thrown our way. We are healthcare leaders with a passion for the advancement of proton therapy. Let us show you what we can do.

Recent Case Study

We have a proven track record of turning loss into opportunity.

Find out how we took a struggling proton center and made it a success with a few key improvements to the operating plan and structure.

Play Video

Partnerships for growth.

We don't simply sell services. Our relationships are designed to be lasting partnerships.

“We approach every relationship with a new client as an opportunity to develop a lasting partnership. We’re in this for the long haul. Proton therapy isn’t going anywhere and we’re going to be around to make sure every center we engage with is successful.”

Tom thumbnail 150px 2

Tom Welch, CEO

Bring us to the table to help drive your next proton therapy venture.

We have a diverse set of skills that will deliver a competitive advantage and guide your team on the path to growth and excellence.

Frequently Asked Questions

We have a combined experience at 8 proton therapy projects and centers. 

We have relationships with many potential investment groups and financial institutions. We have a deep understanding of proton therapy finance and can help navigate your project through the entire funding process. 

We also have a vast understanding of all radiation oncology finance, development and operations. If you are looking to develop a traditional radiation oncology facility, we would love to hear from you.

We purchased the Oklahoma Proton Center out of bankruptcy in early 2019. Since then, the center has seen a tremendous growth in patient volume and a comparable decline in operating expenses.